Because PAH is progressive, ongoing risk assessment is an essential part of PAH management. Once diagnosed, the overall treatment goal for people with PAH is to achieve and maintain a low-risk status ...

At Janssen, our mission is to put the needs and well-being of the people we serve as a top priority. As part of the larger healthcare ecosystem, we also recognize our responsibility to listen to and ...

Pulmonary embolism (PE) is a common and potentially life-threatening condition with presentations ranging from mild symptoms to circulatory collapse. Early and accurate risk stratification is ...

Group 1 pulmonary hypertension (or pulmonary arterial hypertension) is a rare, highly complex, and progressive disorder that is incurable and ultimately can lead to premature death. PAH causes ...

COPD diagnosis Researchers have proposed that the COPD Assessment Test (CAT) be used as a US Food and Drug Administration (FDA) clinical outcomes assessment tool. Members of the COPD Biomarker ...

myCOPD can be used in the NHS while more evidence is generated, to deliver pulmonary rehabilitation programmes for adults with chronic obstructive pulmonary disease (COPD) who cannot have or do not ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Idiopathic Pulmonary Fibrosis pipeline constitutes 80+ key companies continuously working towards developing 100+ ...

We performed a randomized trial comparing goal-directed therapy guided by a pulmonary-artery catheter with standard care without the use of a pulmonary-artery catheter. The subjects were high-risk ...

During the first minutes of extrauterine life, the pulmonary circulation undergoes marked dilation with a 10-fold increase of pulmonary arterial flow, allowing the newborn lung to adapt and fulfill ...

Researchers say that pulmonary rehabilitation (PR) programmes for patients with moderate to severe chronic obstructive pulmonary disease (COPD) should include sleep assessment. The recommendation ...